Teleflex Inc. (TFX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Symbol and logo of brand teleflex.com (TFX)

Teleflex Incorporated (TFX) margins are based on UroLift innovations and M&A efficiency. The company's historical EV/EBITDA dynamics demonstrate stability, where the value 18.21 captures the metric level. Seamless logistics are ensured by strict outsourcing regulations for consumables. Growth potential is driven by an aging population and the development of a high-margin vascular portfolio in the outpatient segment.

TFX Teleflex Corp: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/10/2026
Original product of Teleflex Inc.

The EV/EBITDA ratio compares the total value of assets and debt with operating profit, excluding the impact of taxes and depreciation to determine the actual value of the business. For Teleflex Incorporated (TFX), with its recurring demand for medical consumables, the business's EV/EBITDA history reflects the resilience of its operating margin of safety and the accuracy of the market valuation of the company's defensive profile.

Competitors of Teleflex Incorporated (TFX)

EV/EBITDA Multiple ISRG (Intuitive Surgical Inc)|Total Company Value to Operating Income Before Depreciation Ratio Danaher Corporation Inc. (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (steris.com) - Enterprise Value to Operating Income Before Depreciation|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BAX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MASI|STVN (Stevanato Group Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Merit Medical Systems (MMSI)|NVST (envistaco.com) - Business Value to Operating Income Before Depreciation|ICU Medical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Dentsply Sirona Inc XRAY|LMAT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AtriCure Medical (ATRC) - Enterprise Value to EBITDA Ratio|STAA: EV/EBITDA Multiple|Company Value to EBITDA ChromaDex (NAGE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZimVie|Enterprise Value to Operating Income Before Depreciation ANGO (AngioDynamics Inc)|Enterprise Value to EBITDA Ratio CERS (Cerus Corp)|Enterprise Value to Operating Income Before Depreciation Ratio TKNO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Monogram Technologies MGRM|Total Company Value to Operating Income Before Depreciation Ratio Sharps Technology Inc (STSS)|INFU: Enterprise Value to EBITDA Ratio|Utah Medical Products Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|KRMD: EV/EBITDA Multiple|Company Value to EBITDA Nyxoah S.A (NYXH)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Microbot Medical Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PDEX|EV/EBITDA Multiple ZTEK|ELUT - Company Value to EBITDA|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|NXGL (NEXGEL Inc) - Company Value to Operating Income Before Depreciation Ratio|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HBIO: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|FEMY: EV/EBITDA Multiple|Company Value to EBITDA Meihua Medical Technologies Co., Ltd. (MHUA)|Enterprise Value to EBITDA Ratio POAI|Enterprise Value to Operating Income Before Depreciation CJMB (Callan JMB Corp)|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|NURO (neurometrix.com) - Business Value to Operating Income Before Depreciation